JP2020526530A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020526530A5 JP2020526530A5 JP2020500810A JP2020500810A JP2020526530A5 JP 2020526530 A5 JP2020526530 A5 JP 2020526530A5 JP 2020500810 A JP2020500810 A JP 2020500810A JP 2020500810 A JP2020500810 A JP 2020500810A JP 2020526530 A5 JP2020526530 A5 JP 2020526530A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- lipid
- peptide antigens
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762530498P | 2017-07-10 | 2017-07-10 | |
| US62/530,498 | 2017-07-10 | ||
| PCT/CA2017/051336 WO2019010560A1 (en) | 2017-07-10 | 2017-11-09 | PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION USING LIPID VESICLE PARTICLES OF A DEFINED SIZE, AND USES THEREOF |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020526530A JP2020526530A (ja) | 2020-08-31 |
| JP2020526530A5 true JP2020526530A5 (OSRAM) | 2020-12-10 |
| JP7409594B2 JP7409594B2 (ja) | 2024-01-09 |
Family
ID=65000992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020500810A Active JP7409594B2 (ja) | 2017-07-10 | 2017-11-09 | 医薬組成物、規定のサイズの脂質ベシクル粒子を使用する調製物のための方法、及びそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200230057A1 (OSRAM) |
| EP (1) | EP3651733A4 (OSRAM) |
| JP (1) | JP7409594B2 (OSRAM) |
| CN (1) | CN111093623A (OSRAM) |
| AU (1) | AU2017423053A1 (OSRAM) |
| CA (1) | CA3069019A1 (OSRAM) |
| WO (1) | WO2019010560A1 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3768242A4 (en) * | 2018-03-20 | 2021-12-08 | ImmunoVaccine Technologies Inc. | METHODS AND COMPOSITIONS FOR THE TARGETED DELIVERY OF ACTIVE SUBSTANCES AND IMMUNMODULATORY AGENTS TO LYMPH NODES |
| MA53543A (fr) | 2018-09-04 | 2021-07-14 | Treos Bio Ltd | Vaccins peptidiques |
| SG11202108896UA (en) * | 2019-02-15 | 2021-09-29 | Cleveland Clinic Found | Vaccine adjuvants and formulations |
| CA3136066A1 (en) * | 2019-04-05 | 2020-10-08 | Sumitomo Dainippon Pharma Co., Ltd. | Water soluble adjuvant and composition containing same |
| BR112021023726A2 (pt) | 2019-05-25 | 2022-02-15 | Infectious Disease Res Inst | Composição e método para secagem por pulverização de uma emulsão de vacina adjuvante |
| US20230348935A1 (en) * | 2020-09-24 | 2023-11-02 | Nant Holdings Ip, Llc | Vaccine compositions for mucosal immune response |
| EP4216934A4 (en) * | 2020-09-28 | 2024-11-06 | ImmunoVaccine Technologies Inc. | LIPID COMPOSITIONS COMPRISING POLYNUCLEOTIDE ANTIGENS |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906110A (en) * | 1959-09-29 | Silencing attachment for seamless | ||
| ATE512669T1 (de) | 2004-01-07 | 2011-07-15 | Biomedical Res Models Inc | Verfahren zur anpassung der immunantwort an ein antigen oder immunogen |
| CN102056622B (zh) | 2008-06-05 | 2016-04-06 | 免疫疫苗技术有限公司 | 包含脂质体、抗原、多核苷酸和含疏水物质的连续相的载体的组合物 |
| JP5429710B2 (ja) | 2009-03-30 | 2014-02-26 | 独立行政法人放射線医学総合研究所 | 治療薬剤の標的部位への集積及び放出を追跡可能な治療薬剤含有リポソームおよびその製造方法 |
| KR101102834B1 (ko) * | 2010-02-24 | 2012-01-05 | 충남대학교산학협력단 | 신규한 리포좀 제조 방법 및 장치 |
| CU20100144A7 (es) | 2010-07-06 | 2012-06-21 | Centro Inmunologia Molecular | Composiciones vacunales a base de sticholisina encapsulada en liposomas |
| EP2709590A4 (en) | 2011-05-11 | 2015-05-13 | Nanovalent Pharmaceuticals Inc | REINFORCED GROWTH INHIBITION OF OSTEOSARCOMS THROUGH CYTOTOXIC POLYMERIZED LIPOSOMAL NANOPARTICLES TO AIM AT THE ALCAM CELL SURFACE RECEPTOR |
| CN113876945A (zh) * | 2011-10-06 | 2022-01-04 | 免疫疫苗技术有限公司 | 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用 |
| KR102284689B1 (ko) * | 2011-10-21 | 2021-08-02 | 셀라토 파마슈티칼즈, 인코포레이티드 | 동결건조된 리포좀 |
| ES2721325T3 (es) * | 2011-11-04 | 2019-07-31 | Nitto Denko Corp | Método para producir de manera estéril partículas de lípido-ácido nucleico |
| HRP20230655T1 (hr) | 2012-07-05 | 2023-10-13 | Taiwan Liposome Company, Ltd. | Metode liječenja artritisa |
| US9693958B2 (en) * | 2013-03-15 | 2017-07-04 | Cureport, Inc. | Methods and devices for preparation of lipid nanoparticles |
| CA2994032C (en) * | 2015-08-19 | 2020-08-04 | Shanghai Ginposome Pharmatech Co., Ltd. | Liposomes with ginsenoside as membrane material and preparations and use thereof |
| CA3005127C (en) | 2015-11-18 | 2023-01-24 | Immunovaccine Technologies Inc. | Adjuvanting systems and water-free vaccine compositions comprising a polyi:c polynucleotide adjuvant and a lipid-based adjuvant |
| JP6884783B2 (ja) | 2015-12-08 | 2021-06-09 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドChia Tai Tianqing Pharmaceutical Group Co., Ltd. | リポソームの製造方法 |
-
2017
- 2017-11-09 US US16/629,780 patent/US20200230057A1/en not_active Abandoned
- 2017-11-09 CN CN201780094129.5A patent/CN111093623A/zh active Pending
- 2017-11-09 WO PCT/CA2017/051336 patent/WO2019010560A1/en not_active Ceased
- 2017-11-09 JP JP2020500810A patent/JP7409594B2/ja active Active
- 2017-11-09 CA CA3069019A patent/CA3069019A1/en active Pending
- 2017-11-09 AU AU2017423053A patent/AU2017423053A1/en not_active Abandoned
- 2017-11-09 EP EP17917340.6A patent/EP3651733A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7604519B2 (ja) | Ｒｎａコンストラクトおよびその使用 | |
| Riccardi et al. | Liposomes, transfersomes and niosomes: production methods and their applications in the vaccinal field | |
| Nordly et al. | Immunity by formulation design: induction of high CD8+ T-cell responses by poly (I: C) incorporated into the CAF01 adjuvant via a double emulsion method | |
| US8926994B2 (en) | Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity | |
| US11060096B2 (en) | RNA-based compositions and adjuvants for prophylactic and therapeutic treatment | |
| Li et al. | Rational design of polymeric hybrid micelles to overcome lymphatic and intracellular delivery barriers in cancer immunotherapy | |
| JP2025107179A (ja) | 治療に好適なｒｎａ製剤 | |
| KR101308591B1 (ko) | 양이온성 지질을 포함하는 음이온성 약물 전달체 및 그 제조방법 | |
| CN103372217B (zh) | 聚合物纳米载体制剂及其制备方法和应用 | |
| JP2014522842A5 (OSRAM) | ||
| Avila et al. | Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules | |
| JP2018065821A5 (OSRAM) | ||
| CN105980447A (zh) | 二氧化硅囊泡的合成方法及其用途 | |
| JP7409594B2 (ja) | 医薬組成物、規定のサイズの脂質ベシクル粒子を使用する調製物のための方法、及びそれらの使用 | |
| WO2023000403A1 (zh) | 一种新型冠状病毒亚蛋白纳米疫苗及其制备方法和应用 | |
| WO2016062227A1 (zh) | 聚乙二醇化磷脂为载体的胶束多肽疫苗 | |
| Mody et al. | Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions | |
| Marin et al. | Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine | |
| US20240398918A1 (en) | Design of immunostimulatory protein-core spherical nucleic acids | |
| WO2026007297A1 (zh) | 一种高效跨粘膜障碍并诱导粘膜免疫强化的多功能仿生递送平台的制备方法及应用 | |
| Palumbo et al. | Bacterial invasin: structure, function, and implication for targeted oral gene delivery | |
| CN102369242B (zh) | 包含疏水化聚氨基酸的聚离子复合物及其用途 | |
| JPWO2022244825A5 (OSRAM) | ||
| JP2003526692A (ja) | ポリヌクレオチド組成物 | |
| Gupta et al. | Immunomodulatory potential of nanomaterials: Interaction with the immune system |